Vaccicure Limited

Active08988870 Private limited company

Incorporated: 9 April 2014 (12 years)
Industry: Other professional, scientific and technical activities n.e.c. (74909)
Directors: Lynda Youngpeter Sutton
John Henry Wingen Jr.
Owned by: Cancer Advances Inc
Accounts type: Small
Region: Greater London
Address: 101 New Cavendish Street
1st Floor South
London
W1W 6XH

Filing status

Accounts due: 6 October 2025
Last accounts: 31 December 2023
Conf. stmt due: 17 July 2027
Last conf. stmt: 3 July 2026

Officers 2 active

Officer details are public data from the Companies House register.

Sutton, Lynda Youngpeter

Director · Appointed 9 April 2014

American

Born June 1956 (70)

Wingen, Jr., John Henry

Director · Appointed 9 April 2014

American

Born May 1958 (68)

Officer history (6 former)

1 November 2026

Resigned Cohen, Laurence John as Director

28 June 2024

Resigned Stern, Warren Charles, Dr as Director

25 July 2022

Resigned Cato, Jr., Allen Easley as Director

1 April 2021

Resigned Mccracken, Lee Roy as Director

27 December 2019

Resigned Fowle, Arthur Sydney Edward, Dr as Director

1 November 2016

Resigned Ferrier, Ian Rudolf, Dr as Director

11 July 2016

Appointed Mccracken, Lee Roy as Director

11 July 2016

Appointed Stern, Warren Charles, Dr as Director

11 July 2016

Appointed Fowle, Arthur Sydney Edward, Dr as Director

7 July 2015

Appointed Cohen, Laurence John as Director

9 April 2014

Appointed Sutton, Lynda Youngpeter as Director

9 April 2014

Appointed Ferrier, Ian Rudolf, Dr as Director

9 April 2014

Appointed Cato, Jr., Allen Easley as Director

9 April 2014

Appointed Wingen, Jr., John Henry as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Cancer Advances Inc

Corporate entity · Notified 6 April 2016

Owns 75–100% of shares

Holds 75–100% of voting rights

Right to appoint and remove directors

Has significant influence or control

Corporation

Financials

Balance sheet as at 31 December 2023 · small accounts

Net Assets: (£1,174,699)
Cash: £973
Employees: 8

Current Ratio: 0.1x

Trend

Net Assets

Balance sheet detail

	2023	2022	2021	2020	2019
Current Assets	£973		£945	£49,846	£2,315
Cash	£973		£944	£49,081	£1,550
Creditors (< 1 year)	£7,200	£9,257	£24,810	£31,134	£118,436
Creditors (> 1 year)	£1,168,472	£1,156,964	£1,122,554	£1,140,086	£1,186,503
Net Current Assets	(£6,227)	(£9,257)	(£23,865)	£18,712	(£116,121)
Net Assets	(£1,174,699)	(£1,166,221)	(£1,146,419)	(£1,121,374)	(£1,302,624)
Shareholder Funds	(£1,174,699)	(£1,166,221)	(£1,146,419)	(£1,121,374)	(£1,302,624)